Pharma companies are separating consumer healthcare businesses to drive growth, facing challenges in a competitive market.

According to Elara Capital’s Domestic Liquidity Tracker, the changes in pharma and tech were led by HDFC MF, ICICI Prudential MF, and SBI Mutual Fund.

Cipla shares broke out above ₹1,580–₹1,590 on strong volumes, with technical indicators signaling further gains.

Nifty Pharma index closed up 0.95% at 22177.7 today. The index is down 1.00% over last one month. Among the constituents, Mankind Pharma Ltd gained 3.73%, Cipla Ltd jumped 3.02% and Dr Reddys ...

Benchmark indices Nifty and Sensex stretched their winning run to a sixth straight session on Thursday, August 21, lifted by pharma, oil & gas and banking stocks. The midcap and smallcap index, ...

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD)Appro ...

CHENNAI: Indian equity markets ended Thursday’s session with modest gains, supported by financials and Reliance Industries, ...

An update from Theravance Biopharma ( ($TBPH) ) is now available. On August 15, 2025, Theravance Biopharma and Mylan entered into a Settlement ...

Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the ...

Indian drugmaker Glenmark Pharmaceuticals reported a decline in first-quarter adjusted profit on Thursday, hurt by price erosion in key North American and European markets.